Article
Sex-Dependent Effects of CYP2D6 on the Pharmacokinetics of Berberine in Humans.
Clinical pharmacology and therapeutics - 1 Jan 2025
Blöcher Jonas A, Meyer-Tönnies Marleen J, Morof Felix, Rönnpagel Vincent, Bethmann Jonas, Vollmer Marcus, Engeli Stefan, Tzvetkov Mladen V
Abstract excerpt
An over-the-counter product berberine (a major alkaloid in goldenseal) is a substrate of the uptake transporter OCT1 and the metabolizing enzyme CYP2D6. The two genes exhibit common functional polymorphisms. Approximately 9% of Europeans and white Americans are either poor CYP2D6 metabolizers or poor OCT1 transporters. In this study, we investigated the effects of OCT1 and CYP2D6 polymorphisms on berberine...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
